Most just lately, it's been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar places as classical opioid receptors, it binds to a wide array of endogenous opioids. Unlike most opioid receptors, this receptor functions being a scavenger https://ramseyq071gon1.wikihearsay.com/user